Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13

Klingler, Maximilian; Rangger, Christine; Summer, Dominik; Kaeopookum, Piriya; Decristoforo, Clemens; von Guggenberg, Elisabeth

doi:10.3390/ph12020088

Open AccessCorrection

Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13

by

Maximilian Klingler

,

Christine Rangger

,

Dominik Summer

,

Piriya Kaeopookum

,

Clemens Decristoforo

and

Elisabeth von Guggenberg

^*

Department of Nuclear Medicine, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria

^*

Author to whom correspondence should be addressed.

Pharmaceuticals 2019, 12(2), 88; https://doi.org/10.3390/ph12020088

Submission received: 11 June 2019 / Accepted: 12 June 2019 / Published: 13 June 2019

(This article belongs to the Special Issue Targets, Tracers and Translation – Novel Radiopharmaceuticals Boost Nuclear Medicine)

Download

Browse Figure

Versions Notes

In our paper [1], an error unfortunately occurred in Figure 1. We therefore would like to provide the readers with the corrected figure and apologize for this inconvenience.

Reference

Klingler, M.; Rangger, C.; Summer, D.; Kaeopookum, P.; Decristoforo, C.; von Guggenberg, E. Cholecystokinin-2 Receptor targeting with novel C-terminally stabilized HYNIC-Minigastrin Analogs radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13. [Google Scholar] [CrossRef] [PubMed]

Figure 1. Amino acid sequence and chemical structure of (a) HYNIC-MGS5 and (b) HYNIC-MGS11.

© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Klingler, M.; Rangger, C.; Summer, D.; Kaeopookum, P.; Decristoforo, C.; von Guggenberg, E. Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13. Pharmaceuticals 2019, 12, 88. https://doi.org/10.3390/ph12020088

AMA Style

Klingler M, Rangger C, Summer D, Kaeopookum P, Decristoforo C, von Guggenberg E. Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13. Pharmaceuticals. 2019; 12(2):88. https://doi.org/10.3390/ph12020088

Chicago/Turabian Style

Klingler, Maximilian, Christine Rangger, Dominik Summer, Piriya Kaeopookum, Clemens Decristoforo, and Elisabeth von Guggenberg. 2019. "Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13" Pharmaceuticals 12, no. 2: 88. https://doi.org/10.3390/ph12020088

APA Style

Klingler, M., Rangger, C., Summer, D., Kaeopookum, P., Decristoforo, C., & von Guggenberg, E. (2019). Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13. Pharmaceuticals, 12(2), 88. https://doi.org/10.3390/ph12020088

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13

Reference

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI